1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk (NCI) is sponsored by National Cancer Institute (NCI). This funding opportunity encourages research using existing data, such as the PLCO biorepository, to study cancer etiology and early detection biomarkers. This aligns with the applicant's mission to discover environmental causes of cancer and drivers of prognosis.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes | Division of Cancer Prevention 4. Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes * Grantsmanship Resources # Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes Mon, September 7, 2026: 12:00p. m.
UTC Type of Funding Opportunity Clinical Trial Not Allowed Announcement Number And URL PAR-25-095 (R01 Clinical Trial Not Allowed) Screening and Early Detection NCI'S PDQ® Evidence-Based Summaries * Screening/Detection/Testing for Cancer * Supportive and Palliative Care * Cancer Prevention, Specific Cancers, Clinical Trials * Cancer Screening Topics For People Who Have No Symptoms * Managing The Side Effects of Cancer and Its Treatment * US Preventive Services Task Force Recommendations About Cancer Division of Cancer Prevention at the National Cancer Institute [](https://www.
facebook. com/cancer. gov) [](https://www.
linkedin. com/showcase/cancer-prevention/)
According to the current listing, eligibility includes: Not explicitly stated in the snippet, but NCI grants are typically open to academic and research institutions. Confirm the full requirements in the official notice before applying.
Applications for Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk (NCI) are due October 5, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk (NCI) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article